We Develop Advanced Technologies for Continuous Virus Production that Enable Fast & Scalable Manufacturing of Viral Gene Therapies and Vaccines

ContiVir is a €1.1 million research project of the

Max-Planck-Institute with the vision of revolutionizing the manufacturing of viral gene therapies and vaccines.

​

We aim to provide a unified platform technology for virus production & purification that can produce virus particles at tenfold efficiency compared to today.

​

​

Learn more About Us.